This site is intended for US healthcare professionals
Product Information
VIVITROL®
(naltrexone for extended-release injectable suspension)
Publications
Alkermes Sponsored Phase 3 Clinical Trials
Apr 2005
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial
JAMA
AUTHOR(S)
Apr 2011
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
The Lancet
AUTHOR(S)
Sep 2013
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
Addiction
AUTHOR(S)